{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:02:48Z","timestamp":1793754168413,"version":"4.6.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T00:00:00Z","timestamp":1419379200000},"content-version":"vor","delay-in-days":388,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jacc.2013.10.029","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T16:20:07Z","timestamp":1387210807000},"page":"D34-D41","source":"Crossref","is-referenced-by-count":2241,"special_numbering":"S","title":["Updated Clinical Classification of Pulmonary Hypertension"],"prefix":"10.1016","volume":"62","author":[{"given":"Gerald","family":"Simonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gatzoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Adatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Celermajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardeschir","family":"Ghofrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Gomez Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Krishna Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Landzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto F.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Olschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan M.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rogiero","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2013.10.029_bib1","series-title":"Primary Pulmonary Hypertension. Report on a WHO Meeting","first-page":"7","year":"1975"},{"issue":"Supl","key":"10.1016\/j.jacc.2013.10.029_bib2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.029_bib3","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.029_bib4","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.ehj.2004.09.014","article-title":"Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology","volume":"25","author":"Galie","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.10.029_bib5","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","year":"2009","journal-title":"Eur Respir J"},{"issue":"Suppl","key":"10.1016\/j.jacc.2013.10.029_bib6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"54","author":"Machado","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.029_bib7","first-page":"40865","article-title":"Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia","author":"Harrison","year":"2003","journal-title":"J\u00a0Med Genet"},{"key":"10.1016\/j.jacc.2013.10.029_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/thx.2003.11890","article-title":"Endoglin germline mutation in\u00a0a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension","volume":"59","author":"Chaouat","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.jacc.2013.10.029_bib9","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/humu.21605","article-title":"Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension","volume":"32","author":"Nasim","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jacc.2013.10.029_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/CIRCGENETICS.111.961888","article-title":"Whole exome sequencing to identify a novel gene (Caveolin-1) associated with human pulmonary arterial hypertension","volume":"5","author":"Austin","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2013.10.029_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A\u00a0novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib12","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1183\/09031936.00086308","article-title":"Fenfluramine-like cardiovascular side-effects of benfluorex","volume":"33","author":"Boutet","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.029_bib13","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1183\/09031936.00188611","article-title":"Pulmonary hypertension with benfluorex exposure","volume":"40","author":"Savale","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.029_bib14","doi-asserted-by":"crossref","first-page":"e10128","DOI":"10.1371\/journal.pone.0010128","article-title":"benfluorex and unexplained valvular heart disease: a case-control study","volume":"5","author":"Frachon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jacc.2013.10.029_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.leukres.2008.09.026","article-title":"Reversible severe pulmonary hypertension secondary to dasatinib in a patient with chronic myeloid leukaemia","volume":"33","author":"Rasheed","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.jacc.2013.10.029_bib16","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.111.079921","article-title":"Pulmonary hypertension in patients treated by dasatinib","volume":"125","author":"Montani","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.029_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000335064","article-title":"Sildenafil therapy for interferon-\u03b21-induced pulmonary arterial hypertension: a case report","volume":"120","author":"Caravita","year":"2011","journal-title":"Cardiology"},{"key":"10.1016\/j.jacc.2013.10.029_bib18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s10620-010-1220-7","article-title":"Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C","volume":"55","author":"Dhillon","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jacc.2013.10.029_bib19","unstructured":"Savale L, Gunther S, Chaumais M-C, et al. Pulmonary arterial hypertension in patients treated with interferon. Available at: https:\/\/www.ersnetsecure.org\/public\/prg_congres.abstract?ww_i_presentation=63109. Accessed November 2013."},{"key":"10.1016\/j.jacc.2013.10.029_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pharmthera.2012.03.006","article-title":"Pharmacology and therapeutic potential of interferons","volume":"135","author":"George","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jacc.2013.10.029_bib21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":"Birth outcomes in pregnant women taking fluoxetine","volume":"335","author":"Chambers","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"14","author":"Kallen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2013.10.029_bib24","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jacc.2013.10.029_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2013.10.029_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wijson","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jacc.2013.10.029_bib27","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2013.10.029_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/cap.2009.0095","article-title":"Pulmonary arterial hypertension in an adolescent treated with methylphenidate","volume":"20","author":"Karaman","year":"2010","journal-title":"J\u00a0Child Adloesc Psychopharmacol"},{"key":"10.1016\/j.jacc.2013.10.029_bib29","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2013.10.029_bib30","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2013.10.029_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.029_bib32","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jacc.2013.10.029_bib33","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2013.10.029_bib34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jacc.2013.10.029_bib35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.200704-541OC","article-title":"Prevalence of HIV-related pulmonary arterial hypertension in the current antiretroviral therapy era","volume":"177","author":"Sitbon","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib36","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.CIR.89.6.2722","article-title":"Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension","volume":"89","author":"Petitpretz","year":"1994","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2013.10.029_bib37","first-page":"675","article-title":"The changing picture of patients with pulmonary arterial hypertension in France","volume":"32","author":"Sitbon","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.10.029_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension","volume":"33","author":"Degano","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.029_bib39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/0016-5085(91)90225-A","article-title":"Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics","volume":"100","author":"Hadengue","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacc.2013.10.029_bib40","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1053\/jhep.2003.50060","article-title":"Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study","volume":"37","author":"Colle","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jacc.2013.10.029_bib41","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1164\/rccm.200804-613OC","article-title":"Portopulmonary hypertension: survival and prognostic factors","volume":"178","author":"Le Pavec","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib42","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1378\/chest.11-0160","article-title":"Portopulmonary hypertension: a report from the U.S.-based REVEAL registry","volume":"141","author":"Krowka","year":"2012","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.jacc.2013.10.029_bib43","first-page":"675","article-title":"The changing picture of patients with pulmonary arterial hypertension in France","volume":"32","author":"Sitbon","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2013.10.029_bib44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/hrt.2006.098848","article-title":"Pulmonary arterial hypertension in adults born with a heart septal defect the Euro Heart Survey on adult congenital heart disease","volume":"93","author":"Engelfriet","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2013.10.029_bib45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2006.09.017","article-title":"Pulmonary arterial hypertension in congenital heart disease: an epidemiologic perspective from a Dutch registry","volume":"120","author":"Duffels","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2013.10.029_bib46","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jacc.2011.03.033","article-title":"Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes","volume":"26","author":"Lowe","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.029_bib47","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.106.627224","article-title":"Congenital heart disease in the general population: changing prevalence and age distribution","volume":"115","author":"Marelli","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.029_bib48","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1161\/01.CIR.0000074210.49434.40","article-title":"Basal pulmonary vascular resistance and nitric oxide responsiveness late after Fontan-type operation","volume":"107","author":"Khambadkone","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.029_bib49","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","article-title":"Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized double-blind placebo-controlled crossover trial","volume":"123","author":"Goldberg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.029_bib50","unstructured":"World Health Organization. Shistosmiasis Fact sheet 115. Updated March 2013."},{"key":"10.1016\/j.jacc.2013.10.029_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.108.803221","article-title":"Cardiopulmonary manifestations of hepatosplenic schistosomiasis","volume":"119","author":"Lapa","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2013.10.029_bib52","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2010.03.065","article-title":"Survival in schistosomiasis-associated pulmonary arterial hypertension","volume":"56","author":"Dos Santos Fernandes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2013.10.029_bib53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1378\/chest.11-0483","article-title":"The role of target therapies in schistosomiasis-associated pulmonary arterial hypertension","volume":"141","author":"Fernandes","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2013.10.029_bib54","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood-2010-02-268193","article-title":"Pulmonary hypertension and nitric oxide depletion in sickle cell disease","volume":"116","author":"Bunn","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2013.10.029_bib55","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1164\/rccm.201111-2082CI","article-title":"Pulmonary complications of sickle cell disease","volume":"185","author":"Miller","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1005565","article-title":"A\u00a0hemodynamic study of pulmonary hypertension in sickle cell disease","volume":"365","author":"Parent","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2013.10.029_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.029_bib58","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/hupa.2002.128059","article-title":"Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases","volume":"33","author":"Haque","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jacc.2013.10.029_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/01.paf.0000257397.92466.50","article-title":"Sickle cell lung disease and sudden death: a retrospective\/prospective study of 21 autopsy cases and literature review","volume":"28","author":"Graham","year":"2007","journal-title":"Am J Forensic Med Pathol"},{"key":"10.1016\/j.jacc.2013.10.029_bib60","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","article-title":"Causes of death in sickle cell disease: an autopsy study","volume":"123","author":"Manci","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2013.10.029_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1183\/09031936.00134410","article-title":"Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease","volume":"39","author":"Fonseca","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacc.2013.10.029_bib62","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jama.2012.358","article-title":"Mortality in adults with sickle cell disease and pulmonary hypertension","volume":"307","author":"Mehari","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2013.10.029_bib63","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2010.08097.x","article-title":"Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies","volume":"149","author":"Barst","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2013.10.029_bib64","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1182\/blood-2010-09-306167","article-title":"Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity","volume":"118","author":"Machado","year":"2011","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.jacc.2013.10.029_bib65","first-page":"D118","article-title":"Pediatric pulmonary hypertension","volume":"62","author":"Ivy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2013.10.029_bib66","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachiery","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2013.10.029_bib67","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl","key":"10.1016\/j.jacc.2013.10.029_bib68","doi-asserted-by":"crossref","first-page":"D92","DOI":"10.1016\/j.jacc.2013.10.024","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"62","author":"Kim","year":"2013","journal-title":"J Am Coll Cardiol"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713058725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109713058725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T20:12:08Z","timestamp":1564949528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109713058725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":68,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0735109713058725"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2013.10.029","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718215559.793502503","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718215559.793492898","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718215559.793492000","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}